title: Evaluation of a whole-blood WBC-reduction filter that saves platelets: in vitro studies.
abstract: BACKGROUND
  In this study, a new WBC-reduction in-line filter that removes WBCs but not platelets was evaluated. Three WBC-reduced blood components were prepared: RBCs, plasma, and platelet concentrates (PCs).
  
  
  METHODS
  Whole-blood components (n = 30) were filtered within 2 to 4 hours after collection and then were centrifuged and separated into RBCs, plasma, and WBC-reduced buffy coat. Saline-adenine-glucose-mannitol solution was added to the RBCS: The WBC-reduced buffy coats were stored overnight; on the following day, PCs were prepared from pooled WBC-reduced buffy coats and stored in a medium composed of approximately 35 percent CPD plasma and 65 percent platelet additive solution (T-Sol, Baxter). The WBC-reduction capacity of the filter, the recovery of cells after filtration, and the in vitro storage of RBCs (n = 10) and platelets (n = 6) were evaluated.
  
  
  RESULTS
  Mean and maximum WBC counts after filtration were 0.08 x 10(6) and 0.3 x 10(6), respectively, per filtered whole-blood unit. Recovery of RBCs (mean values) after filtration was 90 percent in whole-blood components and 73 percent in RBCS: Recovery of platelets (mean values) was 81 percent after filtration and 66 percent in PCS: The in vitro storage study of RBCs showed results comparable with previously published data, except for a lower degree of hemolysis. In the in vitro platelet storage study, results were compared with those of standard preparations. In all essentials, similar results were found.
  
  
  CONCLUSIONS
  The results of the present study suggest that effective WBC reduction meets current standards and satisfactory recovery after filtration. The storage characteristics for RBCs and PCs are similar to those of standard preparations. Use of a whole-blood in-line filter to save platelets is a new option for whole-blood processing, which may simplify WBC reduction and blood component preparation, as well as reduce costs in the future.
authors.affiliation: Department of Transfusion Medicine, Huddinge University Hospital, Stockholm, Sweden. stella.larsson@blod.hs.sll.se
authors.forename: S
authors.initials: S
authors.lastname: Larsson
authors.forename: H
authors.initials: H
authors.lastname: Gulliksson
authors.forename: D
authors.initials: D
authors.lastname: Paunovic
mesh_terms: D001781:Blood Component Removal / Q000295:instrumentation*; D017707:Erythrocyte Transfusion / Q000295:instrumentation*; D006801:Humans; D008851:Micropore Filters; D010951:Plasma Exchange / Q000295:instrumentation*; D017713:Platelet Transfusion / Q000295:instrumentation*